Login
Registrati
Reimposta password
Pubblica & Distribuisci
Soluzioni Editoriali
Soluzioni di Distribuzione
Temi
Pubblicazioni
Riviste
Libri
Atti
Editori
Blog
Contatti
Cerca
Carrello
EUR
USD
GBP
Italiano
English
Deutsch
Polski
Español
Français
Italiano
Home
Riviste
Archives of Industrial Hygiene and Toxicology
Volume 73 (2022): Numero 1 (March 2022)
Accesso libero
Ochratoxin A potentiates citrinin accumulation in kidney and liver of rats
Dubravka Rašić
Dubravka Rašić
,
Srđan Stefanović
Srđan Stefanović
,
Dragan Milićević
Dragan Milićević
,
Marin Mladinić
Marin Mladinić
,
Davor Želježić
Davor Želježić
,
Alica Pizent
Alica Pizent
,
Paško Konjevoda
Paško Konjevoda
e
Maja Peraica
Maja Peraica
| 07 apr 2022
Archives of Industrial Hygiene and Toxicology
Volume 73 (2022): Numero 1 (March 2022)
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Sommario
Articolo
Immagini e tabelle
Bibliografia
Autori
Articoli in questo Numero
Anteprima
PDF
Cita
CONDIVIDI
Article Category:
Original article
Pubblicato online:
07 apr 2022
Pagine:
43 - 47
Ricevuto:
01 ott 2021
Accettato:
01 feb 2022
DOI:
https://doi.org/10.2478/aiht-2022-73-3605
© 2022 Dubravka Rašić, Srđan Stefanović, Dragan Milićević, Marin Mladinić, Davor Želježić, Alica Pizent, Paško Konjevoda, Maja Peraica, published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Figure 1
Kidney ochratoxin A levels in rats treated with OTA doses of 125 μg/kg bw (OTA125) or 250 μg/kg bw (OTA250) alone or in combination with citrinin (CTN) and resveratrol (RSV), both in the dose of 20 mg/kg bw. a different from OTA125 alone; b different from OTA125+CTN; c different from OTA250 alone; d different from OTA250+CTN (P<0.05)
Figure 2
Liver ochratoxin A levels in rats treated with OTA doses of 125 μg/kg bw (OTA125) or 250 μg/kg bw (OTA250) alone or in combination with citrinin (CTN) and resveratrol (RSV), both in the dose of 20 mg/kg bw. a different from OTA125 alone; b different from OTA125+CTN; c different from OTA250 alone (P<0.05)
Figure 3
Kidney citrinin levels in rats treated with OTA doses of 125 μg/kg bw (OTA125) or 250 μg/ kg bw (OTA250) alone or in combination with citrinin (CTN) and resveratrol (RSV), both in the dose of 20 mg/kg bw. a different from CTN alone; b different from OTA250+CTN (P<0.05)
Figure 4
Liver citrinin levels in rats treated with OTA doses of 125 μg/kg bw (OTA125) or 250 μg/ kg bw (OTA250) alone or in combination with citrinin (CTN) and resveratrol (RSV), both in the dose of 20 mg/kg bw. a different from CTN alone (P<0.05)